|
58
|
247
|
4x1nU |
The crystal structure of mupain-1-16 in complex with murinised human upa at ph7.4 |
|
56
|
247
|
4x1rU |
The crystal structure of mupain-1-12 in complex with murinised human upa at ph7.4 |
|
56
|
247
|
4x1pU |
The crystal structure of mupain-1-17 in complex with murinised human upa at ph4.6 |
|
55
|
247
|
4x0wU |
The crystal structure of mupain-1-17 in complex with murinised human upa |
|
57
|
247
|
4x1qU |
The crystal structure of mupain-1 in complex with murinised human upa at ph7.4 |
|
57
|
245
|
4os6A |
Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk604 (bicyclic 2) |
|
56
|
245
|
4os5A |
Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk603 (bicyclic 2) |
|
58
|
245
|
4os2A |
Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk602 (bicyclic 1) |
|
58
|
245
|
4os7A |
Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk607 (bicyclic) |
|
56
|
245
|
4os1A |
Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk601 (bicyclic 1) |
|
57
|
245
|
4os4A |
Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk603 (bicyclic 1) |
|
58
|
245
|
4mnvA |
Crystal structure of bicyclic peptide uk729 bound as an acyl-enzyme intermediate to urokinase-type plasminogen activator (upa) |
|
54
|
245
|
4mnyA |
Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk903 |
|
55
|
245
|
4mnwA |
Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk749 |
|
57
|
245
|
4mnxA |
Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk811 |
|
15
|
125
|
4k24A |
Structure of anti-upar fab atn-658 in complex with upar |
|
54
|
245
|
4jk5A |
Human urokinase-type plasminogen activator (upa) in complex with a bicyclic peptide inhibitor (uk18-d-ser) |
|
55
|
245
|
4jk6A |
Human urokinase-type plasminogen activator (upa) in complex with a bicyclic peptide inhibitor (uk18-d-aba) |
|
54
|
247
|
4h42U |
Synthesis of a weak basic upa inhibitor and crystal structure of complex with upa |
|
57
|
245
|
4glyA |
Human urokinase-type plasminogen activator upa in complex with the two-disulfide bridge peptide uk504 |
|
56
|
246
|
4fuhA |
Crystal structure of the urokinase |
|
61
|
246
|
4fudA |
Crystal structure of the urokinase |
|
58
|
246
|
4fubA |
Crystal structure of the urokinase |
|
61
|
246
|
4fueA |
Crystal structure of the urokinase |
|
63
|
246
|
4fujA |
Crystal structure of the urokinase |
|
56
|
246
|
4fu9A |
Crystal structure of the urokinase |
|
59
|
246
|
4fuiA |
Crystal structure of the urokinase |
|
59
|
246
|
4fu8A |
Crystal structure of the urokinase |
|
56
|
246
|
4fu7A |
Crystal structure of the urokinase |
|
54
|
246
|
4fucA |
Crystal structure of the urokinase |
|
59
|
246
|
4fufA |
Crystal structure of the urokinase |
|
60
|
246
|
4fugA |
Crystal structure of the urokinase |
|
56
|
245
|
3qn7A |
Potent and selective bicyclic peptide inhibitor (uk18) of human urokinase-type plasminogen activator(upa) |
|
54
|
247
|
3pb1E |
Crystal structure of a michaelis complex between plasminogen activator inhibitor-1 and urokinase-type plasminogen activator |
|
58
|
247
|
3oy6U |
The crystal structure of upa complex with peptide inhibitor mh036 at ph4.6 |
|
57
|
247
|
3ox7U |
The crystal structure of upa complex with peptide inhibitor mh027 at ph4.6 |
|
55
|
247
|
3oy5U |
The crystal structure of upa complex with peptide inhibitor mh027 at ph7.4 |
|
55
|
246
|
3mwiU |
The complex crystal structure of urokianse and 5-nitro-1h-indole-2-amidine |
|
59
|
247
|
3m61U |
Crystal structure of complex of urokinase and a upain-1 variant(w3a) in ph4.6 condition |
|
59
|
247
|
3mhwU |
The complex crystal structure of urokianse and 2-aminobenzothiazole |
|
22
|
124
|
3laqA |
Structure-based engineering of species selectivity in the upa-upar interaction |
|
55
|
246
|
3khvA |
Crystal structures of urokinase-type plasminogen activator in complex with 4-(aminomethyl) benzoic acid and 4-(aminomethyl-phenyl)-methanol |
|
49
|
246
|
3kidU |
The crystal structures of 2-aminobenzothiazole-based inhibitors in complexes with urokinase-type plasminogen activator |
|
54
|
245
|
3kgpA |
Crystal structures of urokinase-type plasminogen activator in complex with 4-(aminomethyl) benzoic acid and 4-(aminomethyl-phenyl)-methanol |
|
52
|
245
|
3ig6B |
Low molecular weigth human urokinase type plasminogen activator 2-[6-(3'-aminomethyl-biphenyl-3-yloxy)-4-(3-dimethylamino-pyrrolidin-1-yl)-3,5-difluoro-pyridin-2-yloxy]-4-dimethylamino-benzoic acid complex |
|
25
|
124
|
3bt2A |
Structure of urokinase receptor, urokinase and vitronectin complex |
|
20
|
125
|
3bt1A |
Structure of urokinase receptor, urokinase and vitronectin complex |
|
58
|
247
|
2viqA |
Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator |
|
57
|
247
|
2viwA |
Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator |
|
54
|
262
|
2vntA |
Urokinase-type plasminogen activator inhibitor complex with a 1-(7- sulphoamidoisoquinolinyl)guanidine |
